Pyrimethamine is an anti-parasitic drug used in the prevention and treatment of toxoplasmosis and malaria.

Certificate of Analysis

TestSpecificationResults
DescriptionWhite odorless, crystalline powderWhite odorless, crystalline powder
SolubilitySlightly soluble in acetone, in alcohol, and in chloroform; practically insoluble in water.Complies
Identification
A)  By IRThe IR absorption spectrum of the test sample should be concordant with that of pyrimethamine standardComparable
B)  Chloride testThe solution meets requirements of the test for chloride.Complies
C)  By HPLCThe retention time of major peak in the chromatogram of the sample solution should correspond to the in the chromatogram of the standard preparation, as obtained in the assay.Complies
Melting rangeBetween 2380C to 2420C238.90C
Loss on drying (at 1050)NMT 0.5 % w/w0.1 % w/w
Residue on IgnitionNMT 0.1 %0.07 %
Ordinary Impurities by TLCThe total of any ordinary impurities observed does not exceed 2.0 %Complies
Assay by HPLC (on dried basis)NLT 99.0 % & NMT 101.0%99.8 %

 

Note: – This is just a ready reference specification. We can manufacturer as per Buyer’s Specification & Need.

Material Safety Data Sheet

SECTION 1 – CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

MSDS Identification Name     : Pyrimethamine

 

Supplier                                    :  ATILUS PHARMA PVT. LTD.

 

SECTION 2 – COMPOSITION, INFORMATION ON INGREDIENTS

 

CAS #Chemical Name%EINECS #
58-14-0 2,4-Pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl-.

2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine

<=100200-364-2

 

Synonyms                      :  2,4-Pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl-.

 

Formula                         :  C12H13ClN4

Molecular weight            :  248.7 g/mol

 

SECTION 3 – HAZARDS IDENTIFICATION

3.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008

Acute toxicity, Oral (Category 4), H302

For the full text of the H-Statements mentioned in this Section, see Section 16.

3.2 Label elements

Labelling according Regulation (EC) No 1272/2008

Pictogram

 

Signal word Warning

 

Hazard statement(s)

Hazard statement(s) H302            Harmful if swallowed.

Precautionary statement(s) P264  Wash skin thoroughly after handling.

P270                                           Do not eat, drink or smoke when using this product.

P301 + P312  IF SWALLOWED:      Call a POISON CENTER/ doctor if you feel unwell.

P501                                           Dispose of contents/ container to an approved waste disposal plant.

 

Supplemental Hazard         None

Statements

None

3.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.

 

SECTION 4 – FIRST AID MEASURES

4.1 Description of first-aid measures

General advice

Show this material safety data sheet to the doctor in attendance.

If inhaled

After inhalation: fresh air. Consult doctor if feeling unwell.

In case of skin contact

In case of skin contact: Take off immediately all contaminated clothing. Rinse skin with water/ shower. Consult a physician.

In case of eye contact After eye contact: rinse out with plenty of water. Remove contact lenses.

If swallowed After swallowing: immediately make victim drink water (two glasses at most). Consult a physician.

4.2 Most important symptoms and effects, both acute and delayed

The most important known symptoms and effects are described in the labelling (see section

2.2) and/or in section 11

4.3 Indication of any immediate medical attention and special treatment needed

No data available

 

SECTION 5 – FIRE FIGHTING MEASURES

5.1  Extinguishing media

Suitable extinguishing media

Water Foam Carbon dioxide (CO2) Dry powder

Unsuitable extinguishing media

For this substance/mixture no limitations of extinguishing agents are given.

5.2  Special hazards arising from the substance or mixture Carbon oxides Nitrogen oxides (NOx) Hydrogen chloride gas Combustible. Development of hazardous combustion gases or vapours possible in the event of fire.

5.3  Advice for firefighters Stay in danger area only with self-contained breathing apparatus. Prevent skin contact by keeping a safe distance or by wearing suitable protective clothing.

5.4  Further information Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent fire extinguishing water from contaminating surface water or the ground water system.

 

SECTION 6 – ACCIDENTAL RELEASE MEASURES

6.1  Personal precautions, protective equipment and emergency procedures Advice for non-emergency personnel: Avoid inhalation of dusts. Avoid substance contact. Ensure adequate ventilation. Evacuate the danger area, observe emergency procedures, consult an expert. For personal protection see section 8.

6.2  Environmental precautions

Do not let product enter drains.

6.3  Methods and materials for containment and cleaning up

Cover drains. Collect, bind, and pump off spills. Observe possible material restrictions (see sections 7 and 10). Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.

6.4  Reference to other sections

For disposal see section 13.

 

SECTION 7 – HANDLING AND STORAGE

7.1 Precautions for safe handling

For precautions see section 2.2.

7.2 Conditions for safe storage, including any incompatibilities

Storage conditions Tightly closed. Dry.

Storage stability Recommended storage temperature 2 – 8 °C

Storage class Storage class (TRGS 510): 11: Combustible Solids

7.3  Specific end use(s) Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

 

SECTION 8 – EXPOSURE CONTROLS, PERSONAL PROTECTION

8.1 Control parameters

Ingredients with workplace control parameters

8.2 Exposure controls

Personal protective equipment

 Eye/face protection Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Safety glasses

Skin protection

Skin protection This recommendation applies only to the product stated in the safety data sheet, supplied by us and for the designated use. When dissolving in or mixing with other substances and under conditions deviating from those stated in EN374 please contact the supplier of CE-approved gloves (e.g. KCL GmbH, D-36124 Eichenzell, Internet: www.kcl.de).

Full contact Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: 480 min Material tested:KCL 741 Dermatril.

Splash contact Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: 480 min Material tested:KCL 741 Dermatril.

Body Protection

protective clothing

Respiratory protection required when dusts are generated. Our recommendations on filtering respiratory protection are based on the following standards: DIN EN 143, DIN 14387 and other accompanying standards relating to the used respiratory protection system. Recommended Filter type: Filter type P3.

The entrepeneur has to ensure that maintenance, cleaning and testing of respiratory protective devices are carried out according to the instructions of the producer. These measures have to be properly documented.

Control of environmental exposure

Do not let product enter drains.

 

SECTION 9 – PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

 

  1. a) Appearance Form : Solid
  2. b) Odor                  : Not applicable
  3. c) Odor                   : Not applicable
  4. d) pH : No data available
  5. e) Melting point/freezing point Melting point/range: 233.5 °C – lit.
  6. f) Autoignition :No data available

temperature

  1. g) Decomposition temperature :No data available
  2. h) Viscosity Viscosity, kinematic : No data available

Viscosity, dynamic                      : No data available

  1. i) Explosive properties : No data available
  2. j) Oxidizing properties :No data available

 

9.2 Other safety information

No data available

 

SECTION 10 – STABILITY AND REACTIVITY

10.1 Reactivity

The following applies in general to flammable organic substances and mixtures: in correspondingly fine distribution, when whirled up a dust explosion potential may generally be assumed..

10.2 Chemical stability

The following applies in general to flammable organic substances and mixtures: in correspondingly fine distribution, when whirled up a dust explosion potential may generally be assumed.

10.3 Possibility of hazardous reactions

Violent reactions possible with:

Strong oxidizing agents

10.4 Conditions to avoid

no information available

10.5 Incompatible materials

No data available

10.6 Hazardous decomposition products

In the event of fire: see section 5

 

SECTION 11 – TOXICOLOGICAL INFORMATION

11.1  Information on toxicological effects

Acute toxicity LD50 Oral – Rat – 440 mg/kg Remarks: Behavioral:Tremor. Behavioral:Convulsions or effect on seizure threshold. Behavioral:Ataxia. (RTECS) Inhalation: No data available

Dermal: No data available

Skin corrosion/irritation

No data available

Serious eye damage/eye irritation

No data available

Respiratory or skin sensitization

No data available

Germ cell mutagenicity

No data available

Carcinogenicity

This product is or contains a component that is not classifiable as to its carcinogenicity based on its IARC, ACGIH, NTP, or EPA classification.

Reproductive toxicity Animal experiments have shown that multiple malformations can be induced using pyrimethamine while human studies have found pyrimethamine does not increase the risk of abnormalities during pregnancy.

Specific target organ toxicity – single exposure

No data available

Specific target organ toxicity – repeated exposure

No data available

Aspiration hazard No data available

11.2  Additional Information Endocrine disrupting properties Product:

Assessment  : 

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.

 

SECTION 12 – ECOLOGICAL INFORMATION

 

SECTION 12: Ecological information

12.1 Toxicity

Toxicity to daphnia and other aquatic invertebrates

EC50 – Daphnia magna (Water flea) – 4,8 mg/l  – 48 h Remarks: (ECOTOX Database)

12.2 Persistence and degradability

No data available

12.3 Bioaccumulative potential

No data available

12.4 Mobility in soil

No data available

12.5 Results of PBT and vPvB assessment

This substance/mixture contains no components considered to be either persistent,

bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at

levels of 0.1% or higher.

12.6 Other adverse effects

Discharge into the environment must be avoided.

 

SECTION 13 – DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods

Product

No data available

SECTION 14 – TRANSPORT INFORMATION

 

14.1 UN number

ADR/RID:  –  IMDG:  –  IATA:  –

14.2 UN proper shipping name

ADR/RID:  Not dangerous goods

IMDG:  Not dangerous goods

IATA:  Not dangerous goods

14.3 Transport hazard class(es)

ADR/RID:  –  IMDG:  –  IATA:  –

14.4 Packaging group

ADR/RID:  –  IMDG:  –  IATA:  –

14.5 Environmental hazards

ADR/RID:  no IMDG Marine pollutant: no IATA: no

14.6 Special precautions for user

Further information

Not classified as dangerous in the meaning of transport regulations.

 

SECTION 15 – REGULATORY INFORMATION

15.1 Safety, health and environmental regulations/legislation specific for the

substance or mixture

This material safety data sheet complies with the requirements of Regulation (EC) No.

1907/2006.

National legislation

Seveso III: Directive 2012/18/EU of the

European Parliament and of the Council on the

control of major-accident hazards involving

dangerous substances.                                :Not applicable

SECTION 16 – ADDITIONAL INFORMATION

The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

WhatsApp
+91 9819994077
India Copyrights © 2024 Atilus Pharma All right reserved.
Primetech Nxt
Developed By Primetech NXT